Assisted Reproductive Technology (ART) Market By Procedure (Fresh Donor, Frozen Donor, Fresh Non-Donor, Embryo/Egg Banking and Frozen Non-donor) By Technology (Frozen Embryo Replacement (FER), In-Vitro Fertilization (IVF), AI-IUI (Artificial Insemination - Intrauterine Insemination) and Others - Global Industry Analysis & Forecast to 2027
Published On : August 2018 Pages : 180 Category: Biotechnology Report Code : HC081227
Industry Outlook and Trend Analysis
The Assisted Reproductive Technology (ART) Market was is expected to garner lucrative market share by 2027, while registering itself at a substantial compound annual growth rate (CAGR) during the forecast period. The major factors contributing to the development are the expanding number of infertility cases owing to obesity, rising number of smokers, expanding stress and pollution, fertility debilitating treatments, for example, chemotherapy and ideal administrative system. The elimination of tag "experimental" from egg freezing by the American Society for Reproductive Medicine (ASRM) is likewise anticipated to quicken the development of the market. Various advancements in technology are additionally one of the contributing elements for the market development.
Procedure Outlook and Trend Analysis
In 2022 Fresh non-donor captured the biggest income share. Nonetheless, frozen non-donor is anticipated to encounter lucrative development over the estimate period. Frozen procedure has favorable position over fresh procedure as it is more affordable and the user does not need to experience medicate incitement process and is less invasive. Numerous repayment policies have likewise urged more individuals to give or store their gametes.
Technology Outlook and Trend Analysis
In 2022, In-vitro fertilization ruled the market. Positive repayment strategies and advent of new innovation are a few elements adding to the market development. Factors such as regulatory reforms, standardization of procedures through automation, and government subsidizing for egg/sperm storage are some of the contributing to the development of the IVF market.
Regional Outlook and Trend Analysis
In 2022 Europe commanded the market owing to ascend in the rate of infertility, increasing awareness among individuals for richness treatment, technological progressions and government activities. In June 2017, CDC built up a national general wellbeing activity get ready for prevention, enhanced viability safe treatment, and detection of infertility. North America is likewise anticipated that would witness development in the coming years. This is because of increasing awareness towards different options of fertility, government bolster for the in-vitro treatment and different mechanical and technique up gradation.
Competitive Insights
The major players in the market are Parallabs, Ferring Pharmaceuticals, California Cryobank, Irvine Scientific Sales Company Inc, CooperSurgical Inc, Hamilton Thorne Inc, Origio, OvaScience, Merck Group, Anecova SA and Microm UK Ltd. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Assisted Reproductive Technology (ART) Market is segmented by regions as follows-
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Assisted Reproductive Technology (ART) Market, By Procedure, Estimates and Forecast, 2017-2027 ($Million)
· Fresh Donor
· Frozen Donor
· Fresh Non-Donor
· Embryo/Egg Banking
· Frozen Non-donor
· Assisted Reproductive Technology (ART) Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
· Frozen Embryo Replacement (FER)
· In-Vitro Fertilization (IVF)
· AI-IUI (Artificial Insemination - Intrauterine Insemination)
· Others
· Assisted Reproductive Technology (ART) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
· North America
§ North America Assisted Reproductive Technology (ART) Market, By Country
o U.S. Assisted Reproductive Technology (ART) Market
o Canada Assisted Reproductive Technology (ART) Market
o Mexico Assisted Reproductive Technology (ART) Market
· Europe
§ Europe Assisted Reproductive Technology (ART) Market, By Country
o Germany Assisted Reproductive Technology (ART) Market
o UK Assisted Reproductive Technology (ART) Market
o France Assisted Reproductive Technology (ART) Market
o Russia Assisted Reproductive Technology (ART) Market
o Italy Assisted Reproductive Technology (ART) Market
o Rest of Europe Assisted Reproductive Technology (ART) Market
· Asia-Pacific
§ Asia-Pacific Assisted Reproductive Technology (ART) Market, By Country
o China Assisted Reproductive Technology (ART) Market
o Japan Assisted Reproductive Technology (ART) Market
o South Korea Assisted Reproductive Technology (ART) Market
o India Assisted Reproductive Technology (ART) Market
o Southeast Asia Assisted Reproductive Technology (ART) Market
o Rest of Asia-Pacific Assisted Reproductive Technology (ART) Market
· South America
§ South America Assisted Reproductive Technology (ART) Market
o Brazil Assisted Reproductive Technology (ART) Market
o Argentina Assisted Reproductive Technology (ART) Market
o Columbia Assisted Reproductive Technology (ART) Market
o Rest of South America Assisted Reproductive Technology (ART) Market
· Middle East and Africa
§ Middle East and Africa Assisted Reproductive Technology (ART) Market
o Saudi Arabia Assisted Reproductive Technology (ART) Market
o UAE Assisted Reproductive Technology (ART) Market
o Egypt Assisted Reproductive Technology (ART) Market
o Nigeria Assisted Reproductive Technology (ART) Market
o South Africa Assisted Reproductive Technology (ART) Market
o Rest of MEA Assisted Reproductive Technology (ART) Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2027)
4.1.2. Canada Market States and Outlook (2017-2027)
4.1.3. Mexico Market States and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2027)
4.2.2. France Market States and Outlook (2017-2027)
4.2.3. UK Market States and Outlook (2017-2027)
4.2.4. Russia Market States and Outlook (2017-2027)
4.2.5. Italy Market States and Outlook (2017-2027)
4.2.6. Rest of Europe Market States and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2027)
4.3.2. Japan Market States and Outlook (2017-2027)
4.3.3. Korea Market States and Outlook (2017-2027)
4.3.4. India Market States and Outlook (2017-2027)
4.3.5. Southeast Asia Market States and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2027)
4.4.2. Argentina Market States and Outlook (2017-2027)
4.4.3. Columbia Market States and Outlook (2017-2027)
4.4.4. Rest of South America Market States and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2027)
4.5.2. United Arab Emirates Market States and Outlook (2017-2027)
4.5.3. Egypt Market States and Outlook (2017-2027)
4.5.4. Nigeria Market States and Outlook (2017-2027)
4.5.5. South Africa Market States and Outlook (2017-2027)
4.5.6. Turkey Market States and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)
5. Assisted Reproductive Technology (ART) Market, By Procedure
5.1. Introduction
5.2. Global Assisted Reproductive Technology (ART) Revenue and Market Share by Procedure (2017-2027)
5.2.1. Global Assisted Reproductive Technology (ART) Revenue and Revenue Share by Procedure (2017-2027)
5.3. Fresh Donor
5.3.1. Global Fresh Donor Revenue and Growth Rate (2017-2027)
5.4. Frozen Donor
5.4.1. Global Frozen Donor Revenue and Growth Rate (2017-2027)
5.5. Fresh Non-Donor
5.5.1. Global Fresh Non-Donor Revenue and Growth Rate (2017-2027)
5.6. Embryo/Egg Banking
5.6.1. Global Embryo/Egg Banking Revenue and Growth Rate (2017-2027)
5.7. Frozen Non-donor
5.7.1. Global Frozen Non-donor Revenue and Growth Rate (2017-2027)
6. Assisted Reproductive Technology (ART) Market, By Technology
6.1. Introduction
6.2. Global Assisted Reproductive Technology (ART) Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Assisted Reproductive Technology (ART) Revenue and Revenue Share by Technology (2017-2027)
6.3. Frozen Embryo Replacement (FER)
6.3.1. Global Frozen Embryo Replacement (FER) Revenue and Growth Rate (2017-2027)
6.4. In-Vitro Fertilization (IVF)
6.4.1. Global In-Vitro Fertilization (IVF) Revenue and Growth Rate (2017-2027)
6.5. AI-IUI (Artificial Insemination - Intrauterine Insemination)
6.5.1. Global AI-IUI (Artificial Insemination - Intrauterine Insemination) Revenue and Growth Rate (2017-2027)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2027)
7. Assisted Reproductive Technology (ART) Market, By Region
7.1. Introduction
7.2. Global Assisted Reproductive Technology (ART) Revenue and Market Share by Regions
7.2.1. Global Assisted Reproductive Technology (ART) Revenue by Regions (2017-2027)
7.3. North America Assisted Reproductive Technology (ART) by Countries
7.3.1. North America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2027)
7.3.2. North America Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Assisted Reproductive Technology (ART) by Countries
7.4.1. Europe Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2027)
7.4.2. Europe Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Assisted Reproductive Technology (ART) by Countries
7.5.1. Asia-Pacific Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Assisted Reproductive Technology (ART) by Countries
7.6.1. South America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2027)
7.6.2. South America Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Assisted Reproductive Technology (ART) by Countries
7.7.1. Middle East and Africa Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Parallabs
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Ferring Pharmaceuticals
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. California Cryobank
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Irvine Scientific Sales Company Inc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. CooperSurgical Inc
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Hamilton Thorne Inc
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Origio
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. OvaScience
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. Merck Group
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
8.10. Anecova SA
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Revenue and Market Share
8.11. Microm UK Ltd
8.11.1. Business Overview
8.11.2. Service Portfolio
8.11.3. Strategic Developments
8.11.4. Revenue and Market Share
9. Global Assisted Reproductive Technology (ART) Market Competition, by Manufacturer
9.1. Global Assisted Reproductive Technology (ART) Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Assisted Reproductive Technology (ART) Price By Region (2017-2017)
9.3. Top 5 Assisted Reproductive Technology (ART) Manufacturer Market Share
9.4. Market Competition Trend
10. Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.1. Global Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Assisted Reproductive Technology (ART) Market Forecast by Regions (2017-2027)
10.2.1. North America Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.1.1. United States Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.1.2. Canada Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.1.3. Mexico Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2. Europe Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.1. Germany Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.2. France Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.3. UK Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.4. Russia Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.5. Italy Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3. Asia-Pacific Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.1. China Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.2. Japan Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.3. Korea Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.4. India Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.4. South America Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.4.1. Brazil Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.4.2. Argentina Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.4.3. Columbia Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.4.4. Rest of South America Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5. Middle East and Africa Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.3. Egypt Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.4. Nigeria Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.5. South Africa Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.6. Turkey Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Assisted Reproductive Technology (ART) Market Forecast (2017-2027)
10.3. Assisted Reproductive Technology (ART) Market Forecast by Procedure (2017-2027)
10.3.1. Assisted Reproductive Technology (ART) Forecast by Procedure (2017-2027)
10.3.2. Assisted Reproductive Technology (ART) Market Share Forecast by Procedure (2017-2027)
10.4. Assisted Reproductive Technology (ART) Market Forecast by Technology (2017-2027)
10.4.1. Assisted Reproductive Technology (ART) Forecast by Technology (2017-2027)
10.4.2. Assisted Reproductive Technology (ART) Market Share Forecast by Technology (2017-2027)
List of Tables
11. List of Tables and Figures
Figure United States Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Assisted Reproductive Technology (ART) Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Assisted Reproductive Technology (ART) Revenue and Revenue Share by Procedure (2017-2018)
Figure Global Fresh Donor Revenue and Growth Rate (2017-2018)
Figure Global Frozen Donor Revenue and Growth Rate (2017-2018)
Figure Global Fresh Non-Donor Revenue and Growth Rate (2017-2018)
Figure Global Embryo/Egg Banking Revenue and Growth Rate (2017-2018)
Figure Global Frozen Non-donor Revenue and Growth Rate (2017-2018)
Table Global Assisted Reproductive Technology (ART) Revenue and Revenue Share by Technology (2017-2018)
Figure Global Frozen Embryo Replacement (FER) Revenue and Growth Rate (2017-2018)
Figure Global In-Vitro Fertilization (IVF) Revenue and Growth Rate (2017-2018)
Figure Global AI-IUI (Artificial Insemination - Intrauterine Insemination) Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Assisted Reproductive Technology (ART) Revenue by Regions (2017-2018)
Figure North America Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure North America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2018)
Figure North America Assisted Reproductive Technology (ART) by Countries (2017-2018)
Figure North America Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2018)
Figure United States Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure United States Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Canada Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Mexico Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Europe Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2018)
Figure Europe Assisted Reproductive Technology (ART) by Countries (2017-2018)
Figure Europe Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2018)
Figure Germany Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Germany Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure France Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure UK Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Russia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Italy Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Rest of Europe Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Asia-Pacific Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Assisted Reproductive Technology (ART) by Countries (2017-2018)
Figure Asia-Pacific Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2018)
Figure China Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure China Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Japan Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Korea Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure India Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Southeast Asia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure South America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2018)
Figure South America Assisted Reproductive Technology (ART) by Countries (2017-2018)
Figure South America Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Brazil Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Argentina Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Columbia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Rest of South America Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Middle East and Africa Assisted Reproductive Technology (ART) Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Assisted Reproductive Technology (ART) by Countries (2017-2018)
Figure Middle East and Africa Assisted Reproductive Technology (ART) Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Saudi Arabia Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure United Arab Emirates Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Egypt Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Nigeria Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure South Africa Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Turkey Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Assisted Reproductive Technology (ART) Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2017-2018)
Table Parallabs Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ferring Pharmaceuticals Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table California Cryobank Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Irvine Scientific Sales Company Inc Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CooperSurgical Inc Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hamilton Thorne Inc Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Origio Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table OvaScience Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Group Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Anecova SA Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Microm UK Ltd Assisted Reproductive Technology (ART) Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Assisted Reproductive Technology (ART) Market Share by Manufacturer
Figure Global Assisted Reproductive Technology (ART) Revenue and Market Share by Manufacturer
Table Global Assisted Reproductive Technology (ART) Price by Region (2017-2017)
Figure Top 5 Assisted Reproductive Technology (ART) Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Assisted Reproductive Technology (ART) Revenue (Millions USD) and Growth Rate (2018-2025)
Table Assisted Reproductive Technology (ART) Market Forecast by Regions (2018-2025)
Figure North America Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure United States Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Canada Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Mexico Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Europe Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Germany Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure France Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure UK Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Russia Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Italy Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Rest of Europe Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Asia-Pacific Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure China Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Japan Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Korea Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure India Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Southeast Asia Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure South America Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Brazil Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Argentina Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Columbia Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Rest of South America Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Middle East and Africa Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Saudi Arabia Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure United Arab Emirates Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Egypt Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Nigeria Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure South Africa Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Turkey Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Assisted Reproductive Technology (ART) Market Forecast (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Forecast by Procedure (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Market Share Forecast by Procedure (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Forecast by Procedure (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Forecast by Technology (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Market Share Forecast by Technology (2018-2025)
Figure Global Assisted Reproductive Technology (ART) Forecast by Technology (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|